Month: December 2011

-treatment with botulinum toxin type A improves the patients with multiple sclerosis and urinary incontinence associated with hyperactivity of the bladder detrusor muscle

– Similarly, the choice of a suitable absorbent helps to improve the quality of life

Madrid, 2011-December multiple sclerosis is a disease of chronic nature consisting of the appearance of degenerative lesions and demyelinating central nervous system. Depending on the affected site, may manifest different symptoms or alterations of the functions. Alterations in the nerve signals required for the control of urination, can cause problems to retain urine, which is why urinary incontinence often affects patients with sclerosis multiple.

toxin botulinum and quality of life

in a recent study carried out by different authors (Khan S, Game X)(, Kalsi V, Gonzales G, Panicker J, Elneil S, A Apostolidis, Hamid R, Dasgupta P, Kessler TM, Fowler CJ) examined the effect on the quality of life produced by the administration of intravesical injections of botulinum toxin type A in patients with multiple sclerosis, which additionally had a type of urinary incontinence associated with detrusor muscle hyperactivityrefractory to other treatments.

This work showed that with this treatment, and in these specific cases, improving the quality of life for these patients. These are the conclusions drawn by Dr. María Jesús Cancelo Hidalgo, head of section of the service of Gynecology of the Hospital gynecologist University of Guadalajara. Secretary of the SEGO (Spanish society of Gynecology and obstetrics) and a permanent member of the National Observatory of incontinence (INO).

There has been a follow-up of these patients (men and women) by measuring its quality of life, via scales validated for this purpose such as the Urogenital Distress Inventory, the Incontinence Impact Questionnaire and EuroQol-5 questionnaire prior to the injection of botulinum toxin. Four months after the administration of treatment, it was found an improvement in the continence of urine and, consequently, in their quality of life. Although it is known that the improvement of symptoms with the injection of botulinum toxin is temporary and is required to repeat the treatment, the results of the study indicate that the interval between injections in many of the patients had periods of 12-13 months. Others require repeat treatment in spaces of time more shorts.

suitable absorbent and quality of life

the reality is that all forms of incontinence can lead to a negative change in the quality of life of people who suffer from, why the need to urgently improve this aspect is the main objective pursued by different employees in incontinence treatmentswhatever.

The benefit in the quality of life of a performance or treatment is not always related to a reduction in episodes of urine leaks, and so, for example, the use of absorbent adequate improvement the quality of life of patients with incontinence.

The right type of palliative treatment choice, in this case the absorbent, depending on the characteristics of the patient, has a benefit added to avoid undesirable leaks and security therein, which allows to improve social activity, the ability of relationship and ultimately own self-esteem.

In all patients with incontinence of urine, and irrespective of the origin of it, the proper choice of absorbents should be considered following an individualized prescription in those people with multiple sclerosis, with a greater reason. Furthermore, always be feasible, will proceed to the abolition of semi-permanent drilling to avoid potential urinary tract infections, by an absorbent adjusted to the type of incontinence and the user’s profile, in addition, considering not only the functional core aspects of the product, but also all ancillary circumstances thereof (neutralization of the smell, discretion, comfort, adjustability, breathability, etc.) that in many cases, go to occupy the first place.

Similarly, the presence of a properly formed caregiver (see focused INO guides both the health professional and caregiver and patient www.observatoriodelaIncontinencia.es) it is essential to facilitate the quality of life in the late stages of the illness.

what is the National Observatory of incontinence?

With the patient as central objective, INO seeks “ humanize ” the perspective of the discussions and considerations in dealing with this pathological condition, also advocating an improvement of the quality healthcare through the principles of quality of life, freedom of choice and sustainability of the health system.

The Observatory is composed of a group permanent members, all opinion leaders in the field, covering all social groups and medical specialties from different perspectives, and whose purpose is the provide the maximum added value to the discussions within the body. It also has the endorsement of numerous scientific societies and associations.

SCA promotes the Observatory

SCA Hygiene Products S.L. is the promoter of this initiative. It represents a history of innovation in products and services for nearly a century of existence. Marketed brands of such solvency in the sector for example TENA Lady, TENA SCA, absorbent Pants, TENA Men or TENA Bed are present in over 90 countries and are considered a benchmark in quality.

The plurality’s approach issues SCA, is the result of comprehensive vision and inclusive from his leadership. In this same spirit has led to similar initiatives in other countries, as for example in Italy with the Fondazione Italiana Continenza is patron or France with the Institut TENA which is its maximum driving.